Determinants of Ara-C action: biochemical consideration.
D000818:Animals; D003561:Cytarabine / Q000378:metabolism* / Q000627:therapeutic use; D004273:DNA, Neoplasm / Q000378:metabolism; D005260:Female; D007939:Leukemia L1210 / Q000188:drug therapy / Q000378:metabolism*; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy / Q000378:metabolism*; D051379:Mice; D008815:Mice, Inbred Strains
D004273:DNA, Neoplasm; D003561:Cytarabine